We are live on ! Find out more
MD icon

Pediatrix Medical

213 hedge funds and large institutions have $853M invested in Pediatrix Medical in 2024 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 74 increasing their positions, 83 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,550% more call options, than puts

Call options by funds: $429K | Put options by funds: $26K

10% more capital invested

Capital invested by funds: $777M → $853M (+$75.8M)

1.65% more ownership

Funds ownership: 99.46%101.12% (+1.7%)

4% less funds holding

Funds holding: 223213 (-10)

11% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 83

27% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 33

Holders
213
Holders Change
-10
Holders Change %
-4.48%
% of All Funds
3.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
74
Reduced
83
Closed
33
Calls
$429K
Puts
$26K
Net Calls
+$403K
Net Calls Change
+$169K
Name Holding Trade Value Shares
Change
Change in
Stake
BIP
26
Brandes Investment Partners
California
$6.53M +$1.77M +190,232 +41%
DIA
27
Dana Investment Advisors
Wisconsin
$5.69M +$5.28M +567,351 New
Bank of America
28
Bank of America
North Carolina
$5.34M +$1.44M +155,217 +41%
BCM
29
Bridgeway Capital Management
Texas
$5.02M +$165K +17,784 +4%
Principal Financial Group
30
Principal Financial Group
Iowa
$4.68M +$49K +5,265 +1%
Prudential Financial
31
Prudential Financial
New Jersey
$4.64M -$488K -52,444 -10%
First Trust Advisors
32
First Trust Advisors
Illinois
$4.59M +$2.1M +225,527 +97%
Ameriprise
33
Ameriprise
Minnesota
$4.36M -$59.2K -6,364 -1%
Renaissance Technologies
34
Renaissance Technologies
New York
$4.36M +$716K +77,000 +22%
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$4.17M -$77.4K -8,323 -2%
CEI
36
Clark Estates Inc
New York
$3.56M
Voloridge Investment Management
37
Voloridge Investment Management
Florida
$3.52M -$479K -51,519 -13%
Russell Investments Group
38
Russell Investments Group
United Kingdom
$2.8M -$588K -63,246 -18%
Envestnet Asset Management
39
Envestnet Asset Management
Illinois
$2.78M +$254K +27,258 +11%
CCM
40
Cinctive Capital Management
New York
$2.53M +$2.34M +251,770 New
EF
41
Empowered Funds
Pennsylvania
$2.36M +$165K +17,784 +8%
Legal & General Group
42
Legal & General Group
United Kingdom
$2.31M +$9.05K +973 +0.4%
Federated Hermes
43
Federated Hermes
Pennsylvania
$2.28M -$526K -56,559 -20%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$2.27M +$5.29K +569 +0.3%
N
45
Nuveen
North Carolina
$2.24M
Wells Fargo
46
Wells Fargo
California
$2.17M +$283K +30,366 +16%
Nordea Investment Management
47
Nordea Investment Management
Sweden
$2.13M -$20.2K -2,176 -1%
Goldman Sachs
48
Goldman Sachs
New York
$2.06M -$812K -87,294 -30%
SEI Investments
49
SEI Investments
Pennsylvania
$1.84M -$126K -13,520 -7%
Public Sector Pension Investment Board (PSP Investments)
50
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.72M

MD Hedge Fund Activity: Q1 2024 in Review

213 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q1 2024, worth a combined $853M — up 9.8% from $777M a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of MD and 24 opened new positions — a net loss of 9 holders — while 83 trimmed existing stakes and 74 added.

The largest buyer was Pacer Advisors, adding an estimated $18.5M. The largest seller was Citadel Advisors, cutting an estimated $14.3M.

  • 213 institutional investors held Pediatrix Medical (MD) as of Q1 2024, down from 223 in Q4 2023.
  • Funds reported $853M of Pediatrix Medical stock for Q1 2024, up 9.8% quarter-over-quarter.
  • 24 funds opened new Pediatrix Medical positions in Q1 2024 and 33 closed out, a net change of -9 holders.
  • The largest Pediatrix Medical buyer in Q1 2024 was Pacer Advisors, an estimated $18.5M added.
  • The largest Pediatrix Medical seller in Q1 2024 was Citadel Advisors, an estimated $14.3M sold.

Based on aggregated 13F filings for Q1 2024.